Platform Therapeutics, Inc.

ANDOVER, MA · CIK 0002152141 · Biotech

Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.8M
1 Form D · Aug 2026
1 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,750,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2185OCULOGENEX——
2186BIOSUPERIOR TECHNOLOGY INC——
2187NexImmune, Inc.—$35M
2188Platform Therapeutics, Inc.—$1.8M
2189Ceapro Inc.—$7.7M
2190GREENSTONE BIOSCIENCES, INC.—$10M
2191SILCSBIO LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.